查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1575346

乾眼治療藥物市場：按藥物類型、劑型、最終用戶、分銷管道分類 - 全球預測 2025-2030

Dry Eye Medication Market by Drug Type (Over-The-Counter Drugs, Prescription Drugs), Dosage Form (Eye Drops, Gels, Ointments), End-User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年乾眼治療藥物市場規模為29.6億美元，預計2024年將達到32.1億美元，複合年成長率為7.22%，預計到2030年將達到48.3億美元。

乾眼症藥物市場包括旨在緩解乾眼症症狀的藥物，乾眼症的特徵是淚液產生不足或品質不佳。這通常包括人工淚液、發炎藥物、類固醇眼藥水和處方藥，如Cyclosporine和利夫司特。這些治療的需求是由於螢幕使用增加、人口老化和空調廣泛使用等因素導致全球乾眼患者數量迅速增加。主要用途是緩解症狀和治療潛在發炎，以改善淚液產生和品質。該產品針對慢性乾眼患者，特別是老年人和隱形眼鏡使用者，具有廣泛的最終用途，包括醫院、診所和零售藥房。

主要市場統計
基準年[2023] 29.6億美元
預測年份 [2024] 32.1億美元
預測年份 [2030] 48.3億美元
複合年成長率（%） 7.22%

市場成長受到藥物研究進步和公眾對眼睛健康意識提高的正面影響。新興商機包括開發更有針對性的治療方法、個人化醫療方法以及人工智慧技術在個人化診斷和治療中的整合。公司可以透過投資新配方的研發並利用數位健康平台促進病人參與來利用這些機會。然而，市場成長受到嚴格監管核准、藥物潛在副作用以及學名藥的激烈競爭等因素的限制，這可能會限制盈利。

為了克服這些挑戰，創新領域可能包括生物技術的進步，例如基因療法、新型生技藥品和改進的藥物傳遞系統，以提高療效和患者依從性。公司也應專注於建立策略夥伴關係和研究合作，共同開發開創性治療方法。對市場競爭格局的回顧表明，需要敏捷性和持續創新來滿足不斷變化的患者需求。公司應致力於透過獨特的價值提案使自己脫穎而出，例如提供將傳統藥物與生活方式和飲食干預相結合的整體解決方案，以更全面地管理乾眼症。

市場動態：揭示快速發展的乾眼治療市場的關鍵市場洞察

供需的動態交互作用正在改變乾眼藥物市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 增加對醫療基礎設施和藥物研究的投資
    • 停經後婦女乾眼症患病率增加
    • 生活方式的改變及其對眼睛健康的影響
    • 擴大遠端醫療服務以改善獲得眼科護理的機會
  • 市場限制因素
    • 新乾眼治療技術的高研發成本影響市場成長
    • 關於有效管理慢性乾眼症狀的處方要求的患者依從性問題
  • 市場機會
    • 擴大遠端醫療和虛擬就診以方便獲得乾眼治療
    • 增加創新乾眼治療和藥物傳輸系統研發的投資
    • 個人化醫療的不斷成長趨勢導致根據患者個人情況量身訂做乾眼治療解決方案
  • 市場挑戰
    • 乾眼藥物市場缺乏針對不同患者族群的治療解決方案
    • 對乾眼症的認知不足和診斷延遲影響市場成長潛力

波特五力：駕馭乾眼藥物市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解乾眼藥物市場的外部影響

外部宏觀環境因素在塑造乾眼治療藥物市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解乾眼治療藥物市場的競爭狀況

對乾眼治療藥物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣乾眼治療市場供應商的績效評估

FPNV定位矩陣是評估乾眼治療市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製乾眼治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，乾眼治療藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加對醫療基礎設施和藥物研究的投資
      • 停經後女性乾眼症發生率較高
      • 改變生活方式及其對眼睛健康的影響
      • 擴大遠端醫療服務改善獲得眼科護理的機會
    • 抑制因素
      • 乾眼治療新技術的高研發成本影響市場成長
      • 有效管理慢性乾眼症的患者對處方箋要求的依從性問題
    • 機會
      • 遠端醫療和虛擬健康諮詢的擴展使乾眼治療變得更容易
      • 增加創新乾眼治療方法和藥物傳輸系統研發的投資
      • 個人化醫療的不斷發展趨勢提供了基於患者個人資料的客製化乾眼治療解決方案。
    • 任務
      • 乾眼治療藥物市場缺乏針對不同患者族群的治療解決方案
      • 對乾眼症狀的認知不足和診斷延遲影響市場成長潛力
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 乾眼治療市場（依藥物類型）

  • 非處方藥
  • 處方藥

第7章乾眼治療藥物市場（以劑型）

  • 眼藥水
  • 凝膠
  • 軟膏

第8章乾眼治療市場：依最終使用者分類

  • 診所
  • 居家護理
  • 醫院

第9章乾眼治療藥物市場：依通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第10章 北美和南美乾眼治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太乾眼治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲乾眼藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C0036

The Dry Eye Medication Market was valued at USD 2.96 billion in 2023, expected to reach USD 3.21 billion in 2024, and is projected to grow at a CAGR of 7.22%, to USD 4.83 billion by 2030.

The scope of the dry eye medication market encompasses pharmaceutical products aimed at alleviating the symptoms of dry eye syndrome, a condition characterized by insufficient or poor-quality tears. This often includes artificial tears, anti-inflammatory drugs, steroidal eye drops, and prescription medications like cyclosporine and lifitegrast. The necessity for these treatments is driven by factors like increased screen time, aging populations, and pervasive air conditioning use, leading to an upsurge in dry eye cases globally. Applications primarily focus on symptom relief and treating underlying inflammation to improve tear production and quality. End-use segments are broad, including hospitals, clinics, and retail pharmacies, targeting individuals with chronic dry eye, especially prevalent among older adults and contact lens users.

KEY MARKET STATISTICS
Base Year [2023] USD 2.96 billion
Estimated Year [2024] USD 3.21 billion
Forecast Year [2030] USD 4.83 billion
CAGR (%) 7.22%

Market growth is positively influenced by advancements in pharmaceutical research and increasing public awareness of ocular health. The latest opportunities include the development of more targeted therapies, personalized medicine approaches, and the integration of AI technologies in diagnosing and personalizing treatments. Companies can capitalize on these opportunities through investment in R&D for novel drug formulations and leveraging digital health platforms for patient engagement. However, market growth is constrained by factors such as stringent regulatory approvals, potential side effects of medications, and high competition from generic products, which could limit profitability.

To surmount these challenges, innovation areas could involve biotechnological advancements such as gene therapy, novel biologics, and improvement of drug delivery systems to enhance efficacy and patient adherence. Businesses should also focus on creating strategic partnerships and collaborations for the co-development of pioneering treatments. Insights into the market reveal a competitive landscape that demands agility and continuous innovation to cater to evolving patient needs. Companies should aim to differentiate through unique value propositions, such as offering holistic solutions that merge traditional medications with lifestyle and dietary interventions to manage dry eye more comprehensively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dry Eye Medication Market

The Dry Eye Medication Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing investment in healthcare infrastructure and pharmaceutical research
    • Higher incidence rates of dry eye conditions in post-menopausal women
    • Adoption of lifestyle changes and its impact on eye health
    • Expansion of telemedicine services facilitating better access to eye care
  • Market Restraints
    • High cost of research and development for new dry eye treatment technologies impacting market growth
    • Patient adherence issues with prescription requirements for effective management of chronic dry eye conditions
  • Market Opportunities
    • Expansion of telemedicine and virtual health consultations facilitating easier access to dry eye treatments
    • Rising investments in research and development for innovative dry eye therapies and drug delivery systems
    • Growing trend of personalized medicine leading to customized dry eye treatment solutions based on individual patient profiles
  • Market Challenges
    • Shortage of tailored therapeutic solutions for diverse patient demographics in the dry eye medication market
    • Limited awareness and delayed diagnosis of dry eye conditions affecting market growth potential

Porter's Five Forces: A Strategic Tool for Navigating the Dry Eye Medication Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dry Eye Medication Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dry Eye Medication Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dry Eye Medication Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dry Eye Medication Market

A detailed market share analysis in the Dry Eye Medication Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dry Eye Medication Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dry Eye Medication Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dry Eye Medication Market

A strategic analysis of the Dry Eye Medication Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dry Eye Medication Market, highlighting leading vendors and their innovative profiles. These include Aerie Pharmaceuticals, Inc., Alcon Inc., Aldeyra Therapeutics, Inc., Allergan plc, Bausch Health Companies Inc., Eyepoint Pharmaceuticals, Inc., Harrow Health, Inc., Johnson & Johnson Vision, Kala Pharmaceuticals, Inc., Mitotech S.A., Nicox S.A., Novartis International AG, Ocugen, Inc., Otsuka Pharmaceutical Co., Ltd., Oyster Point Pharma, Inc., Pfizer Inc., Regenera Pharma Ltd., Santen Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., and Tarsus Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Dry Eye Medication Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Over-The-Counter Drugs and Prescription Drugs.
  • Based on Dosage Form, market is studied across Eye Drops, Gels, and Ointments.
  • Based on End-User, market is studied across Clinics, Home Care, and Hospitals.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing investment in healthcare infrastructure and pharmaceutical research
      • 5.1.1.2. Higher incidence rates of dry eye conditions in post-menopausal women
      • 5.1.1.3. Adoption of lifestyle changes and its impact on eye health
      • 5.1.1.4. Expansion of telemedicine services facilitating better access to eye care
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of research and development for new dry eye treatment technologies impacting market growth
      • 5.1.2.2. Patient adherence issues with prescription requirements for effective management of chronic dry eye conditions
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of telemedicine and virtual health consultations facilitating easier access to dry eye treatments
      • 5.1.3.2. Rising investments in research and development for innovative dry eye therapies and drug delivery systems
      • 5.1.3.3. Growing trend of personalized medicine leading to customized dry eye treatment solutions based on individual patient profiles
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of tailored therapeutic solutions for diverse patient demographics in the dry eye medication market
      • 5.1.4.2. Limited awareness and delayed diagnosis of dry eye conditions affecting market growth potential
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dry Eye Medication Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Over-The-Counter Drugs
  • 6.3. Prescription Drugs

7. Dry Eye Medication Market, by Dosage Form

  • 7.1. Introduction
  • 7.2. Eye Drops
  • 7.3. Gels
  • 7.4. Ointments

8. Dry Eye Medication Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Home Care
  • 8.4. Hospitals

9. Dry Eye Medication Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Americas Dry Eye Medication Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Dry Eye Medication Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Dry Eye Medication Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aerie Pharmaceuticals, Inc.
  • 2. Alcon Inc.
  • 3. Aldeyra Therapeutics, Inc.
  • 4. Allergan plc
  • 5. Bausch Health Companies Inc.
  • 6. Eyepoint Pharmaceuticals, Inc.
  • 7. Harrow Health, Inc.
  • 8. Johnson & Johnson Vision
  • 9. Kala Pharmaceuticals, Inc.
  • 10. Mitotech S.A.
  • 11. Nicox S.A.
  • 12. Novartis International AG
  • 13. Ocugen, Inc.
  • 14. Otsuka Pharmaceutical Co., Ltd.
  • 15. Oyster Point Pharma, Inc.
  • 16. Pfizer Inc.
  • 17. Regenera Pharma Ltd.
  • 18. Santen Pharmaceutical Co., Ltd.
  • 19. Sun Pharmaceutical Industries Ltd.
  • 20. Tarsus Pharmaceuticals, Inc.

LIST OF FIGURES

  • FIGURE 1. DRY EYE MEDICATION MARKET RESEARCH PROCESS
  • FIGURE 2. DRY EYE MEDICATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRY EYE MEDICATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DRY EYE MEDICATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DRY EYE MEDICATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRY EYE MEDICATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRY EYE MEDICATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRY EYE MEDICATION MARKET DYNAMICS
  • TABLE 7. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DRY EYE MEDICATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DRY EYE MEDICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. DRY EYE MEDICATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. DRY EYE MEDICATION MARKET, FPNV POSITIONING MATRIX, 2023